Foto Med Solutions is categorized under Noncommercial Biological Research Organization in Clovis, CA and active since 1996.
Foto Med Solutions was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Noncommercial Biological Research Organization business, which does work in the B2B market, and is classified as a Noncommercial Biological Research Organization, under code number 5614390 by the NAICS.
If you are seeking more information, feel free to contact Jane Urrutia, Owner at the company’s single location by writing to 725 Pollasky Avenue # 101, Clovis, California CA 93612 or by phoning (559) 299-2679. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Foto Med Solutions |
| Contact Person: | Jane Urrutia, Owner |
| Address: | 725 Pollasky Avenue # 101, Clovis, California 93612 |
| Phone Number: | (559) 299-2679 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biological Research Organization |
| SIC Code: | 8733 |
| NAICS Code: | 5614390 |
| Share This Business: |
Foto Med Solutions was started in 1996 to provide professional Noncommercial Biological Research Organization under the SIC code 8733 and NAICS code 5614390. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jane Urrutia, Owner for inquiries that concern Foto Med Solutions by calling the company number (559) 299-2679, as your correspondence is most welcome. Additionally, the physical location of the single location of Foto Med Solutions can be found at the coordinates 36.82146,-119.70198 as well as the street address 725 Pollasky Avenue # 101 in Clovis, California 93612.
For its online presence, you may visit Foto Med Solutions’s website at and engage with its social media outlets through on Twitter and on Facebook.